PubRank

M E Patarroyo

Author PubWeight™ 108.79‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Amplification of a species-specific DNA fragment of Mycobacterium tuberculosis and its possible use in diagnosis. J Clin Microbiol 1991 5.99
2 Properties of proteins MPB64, MPB70, and MPB80 of Mycobacterium bovis BCG. Infect Immun 1986 3.80
3 Antibodies in malarial sera to parasite antigens in the membrane of erythrocytes infected with early asexual stages of Plasmodium falciparum. J Exp Med 1984 3.49
4 Human antibodies to a Mr 155,000 Plasmodium falciparum antigen efficiently inhibit merozoite invasion. Proc Natl Acad Sci U S A 1984 2.52
5 Mycobacterium leprae antigen-induced suppression of T cell proliferation in vitro. J Immunol 1987 2.27
6 MPB59, a widely cross-reacting protein of Mycobacterium bovis BCG. Int Arch Allergy Appl Immunol 1986 2.25
7 Induction of protective immunity against experimental infection with malaria using synthetic peptides. Nature 1987 1.85
8 Chronic Lyme arthritis. Clinical and immunogenetic differentiation from rheumatoid arthritis. Ann Intern Med 1979 1.79
9 Multiprimer PCR system for differential identification of mycobacteria in clinical samples. J Clin Microbiol 1996 1.68
10 Species-specific identification of Mycobacterium bovis by PCR. Microbiology 1995 1.68
11 Isolation, characterization, and molecular cloning of a specific Mycobacterium tuberculosis antigen gene: identification of a species-specific sequence. Infect Immun 1991 1.63
12 Regulation of the immune response in Plasmodium falciparum malaria. II. Antigen specific proliferative responses in vitro. Clin Exp Immunol 1983 1.53
13 An analysis of in vitro T cell responsiveness in lepromatous leprosy. J Exp Med 1985 1.52
14 Rabbit and human antibodies to a repeated amino acid sequence of a Plasmodium falciparum antigen, Pf 155, react with the native protein and inhibit merozoite invasion. Proc Natl Acad Sci U S A 1986 1.51
15 Production of IL 2 and IFN-gamma by T cells from malaria patients in response to Plasmodium falciparum or erythrocyte antigens in vitro. J Immunol 1985 1.46
16 Agglutination of Plasmodium falciparum-infected erythrocytes from east and west African isolates by human sera from distant geographic regions. Am J Trop Med Hyg 1992 1.41
17 Genetic polymorphism of the Duffy receptor binding domain of Plasmodium vivax in Colombian wild isolates. Mol Biochem Parasitol 1996 1.39
18 Human heart-infiltrating T-cell clones from rheumatic heart disease patients recognize both streptococcal and cardiac proteins. Circulation 1995 1.36
19 Regulation of the immune response in Plasmodium falciparum malaria. III. Proliferative response to antigen in vitro and subset composition of T cells from patients with acute infection or from immune donors. Clin Exp Immunol 1984 1.32
20 A species-specific nucleotide sequence of Mycobacterium tuberculosis encodes a protein that exhibits hemolytic activity when expressed in Escherichia coli. Infect Immun 1995 1.21
21 Association of a B-cell alloantigen with susceptibility to rheumatic fever. Nature 1979 1.15
22 Autoimmunity in Chagas disease cardiopathy: biological relevance of a cardiac myosin-specific epitope crossreactive to an immunodominant Trypanosoma cruzi antigen. Proc Natl Acad Sci U S A 1995 1.15
23 T-cell reactivity against streptococcal antigens in the periphery mirrors reactivity of heart-infiltrating T lymphocytes in rheumatic heart disease patients. Infect Immun 2001 1.11
24 Regulation of the immune response in Plasmodium falciparum malaria. I. Non-specific proliferative responses in vitro and characterization of lymphocytes. Clin Exp Immunol 1983 1.10
25 Amplification of a 500-base-pair fragment from cultured isolates of Mycobacterium bovis. J Clin Microbiol 1999 1.10
26 Immunodiagnosis of parasitic diseases with synthetic peptides. Curr Protein Pept Sci 2003 1.05
27 Viral hepatitis in Colombia: a study of the "hepatitis of the Sierra Nevada de Santa Marta". Hepatology 1985 1.05
28 Identification of B- and T-cell epitopes within the MTP40 protein of Mycobacterium tuberculosis and their correlation with the disease course. Infect Immun 1991 1.05
29 Potent, long lasting systemic antibody levels and mixed Th1/Th2 immune response after nasal immunization with malaria antigen loaded PLGA microparticles. Vaccine 2004 1.02
30 CD4(+) T-cell- and gamma interferon-dependent protection against murine malaria by immunization with linear synthetic peptides from a Plasmodium yoelii 17-kilodalton hepatocyte erythrocyte protein. Infect Immun 1999 1.01
31 Plasmodium falciparum AMA-1 erythrocyte binding peptides implicate AMA-1 as erythrocyte binding protein. Vaccine 2000 1.00
32 Mapping of the linear antigenic determinants from the Leishmania infantum histone H2A recognized by sera from dogs with leishmaniasis. Immunol Lett 1995 1.00
33 Identification of Mycobacterium bovis in bovine clinical samples by PCR species-specific primers. Can J Vet Res 1999 0.99
34 Molecular analysis of HLA DR4-beta 1 gene in malaria vaccinees. Typing and subtyping by PCR technique and oligonucleotides. Parasite Immunol 1991 0.98
35 Identification of Plasmodium falciparum MSP-1 peptides able to bind to human red blood cells. Parasite Immunol 1996 0.98
36 Immunization of cattle with synthetic peptides derived from the Boophilus microplus gut protein (Bm86). Vet Immunol Immunopathol 2002 0.98
37 Leishmania: fine mapping of the Leishmanolysin molecule's conserved core domains involved in binding and internalization. Exp Parasitol 1999 0.97
38 Regulation of the immune response in Plasmodium falciparum malaria: IV. T cell dependent production of immunoglobulin and anti-P. falciparum antibodies in vitro. Clin Exp Immunol 1987 0.96
39 Characterization and localization of Plasmodium falciparum surface antigens on infected erythrocytes from west African patients. Blood 1991 0.95
40 Regulation of hsp70 expression in Trypanosoma cruzi by temperature and growth phase. Mol Biochem Parasitol 1992 0.94
41 Plasmodium vivax: polymorphism in the merozoite surface protein 1 gene from wild Colombian isolates. Exp Parasitol 2000 0.93
42 Isolation and identification of mycobacteria in New World primates maintained in captivity. Vet Microbiol 2004 0.93
43 Identification of the Leishmania infantum P0 ribosomal protein epitope in canine visceral leishmaniasis. Immunol Lett 1995 0.91
44 Plasmodium falciparum acid basic repeat antigen (ABRA) peptides: erythrocyte binding and biological activity. Vaccine 2001 0.91
45 Characterization of the antigenic determinants of the Leishmania infantum histone H3 recognized by antibodies elicited during canine visceral leishmaniasis. Clin Exp Immunol 1996 0.91
46 Studies in owl monkeys leading to the development of a synthetic vaccine against the asexual blood stages of Plasmodium falciparum. Am J Trop Med Hyg 1990 0.90
47 Functional and structural similarity of V gamma 9V delta 2 T cells in humans and Aotus monkeys, a primate infection model for Plasmodium falciparum malaria. J Immunol 2001 0.90
48 Antigenicity of the Leishmania infantum histones H2B and H4 during canine viscerocutaneous leishmaniasis. Clin Exp Immunol 1999 0.89
49 Geographical distribution of Plasmodium falciparum erythrocyte rosetting and frequency of rosetting antibodies in human sera. Am J Trop Med Hyg 1990 0.89
50 During active viscerocutaneous leishmaniasis the anti-P2 humoral response is specifically triggered by the parasite P proteins. Clin Exp Immunol 1995 0.88
51 Plasmodium falciparum EBA-175 kDa protein peptides which bind to human red blood cells. Parasitology 2000 0.87
52 Immunogenic synthetic peptides against mycobacteria of potential immunodiagnostic and immunoprophylactic value. Lepr Rev 1986 0.87
53 Plasmodium falciparum: red blood cell binding studies of peptides derived from histidine-rich KAHRP-I, HRP-II and HRP-III proteins. Acta Trop 2000 0.87
54 Quantum chemical analysis of MHC-peptide interactions for vaccine design. Mini Rev Med Chem 2010 0.86
55 Sequence and diversity of MHC DQA and DQB genes of the owl monkey Aotus nancymaae. Immunogenetics 2000 0.84
56 Biodegradable PLGA microspheres as a delivery system for malaria synthetic peptide SPf66. Vaccine 2001 0.84
57 Mapping of the antigenic determinants of the T. cruzi kinetoplastid membrane protein-11. Identification of a linear epitope specifically recognized by human Chagasic sera. Clin Exp Immunol 2001 0.84
58 Sequence and diversity of DRB genes of Aotus nancymaae, a primate model for human malaria parasites. Immunogenetics 2000 0.83
59 Specific interactions of synthetic peptides derived from P. falciparum merozoite proteins with human red blood cells. Pept Res 1992 0.83
60 Plasmodium falciparum EBA-140 kDa protein peptides that bind to human red blood cells. J Pept Res 2003 0.83
61 Shifting the polarity of some critical residues in malarial peptides' binding to host cells is a key factor in breaking conserved antigens' code of silence. Med Chem 2008 0.83
62 Mapping of antigenic determinants of the T. cruzi hsp70 in chagasic and healthy individuals. Mol Immunol 1993 0.83
63 Two MSA 2 peptides that bind to human red blood cells are relevant to Plasmodium falciparum merozoite invasion. J Pept Res 2000 0.83
64 Remarkably high antibody levels and protection against P. falciparum malaria in Aotus monkeys after a single immunisation of SPf66 encapsulated in PLGA microspheres. Vaccine 2002 0.82
65 Mapping of the linear antigenic determinants of the Leishmania infantum hsp70 recognized by leishmaniasis sera. Immunol Lett 1996 0.82
66 Activation pattern and toxicity of the Cry11Bb1 toxin of Bacillus thuringiensis subsp. medellin. J Invertebr Pathol 2000 0.82
67 Cultivation and characterization of stable Leishmania guyanensis complex axenic amastigotes derived from infected U937 cells. Am J Trop Med Hyg 2001 0.81
68 Malaria vaccines. Curr Opin Immunol 1995 0.81
69 Identification of a particular B cell alloantigen associated with susceptibility to lepromatous leprosy. Lepr Rev 1981 0.81
70 Studies on the humoral immune response to a synthetic vaccine against Plasmodium falciparum malaria. Clin Exp Immunol 1991 0.81
71 Immunoglobulin kappa light-chain V, J, and C gene sequences of the owl monkey Aotus nancymaae. Immunogenetics 2000 0.80
72 Immunization of owl monkeys with a combination of Plasmodium falciparum asexual blood-stage synthetic peptide antigens. Am J Trop Med Hyg 1990 0.80
73 Synthesis, isolation and characterization of Plasmodium falciparum antigenic tetrabranched peptide dendrimers obtained by thiazolidine linkages. J Pept Res 2001 0.80
74 Plasmodium vivax: functional analysis of a highly conserved PvRBP-1 protein region. Mol Biochem Parasitol 2001 0.80
75 Diagnosis of cutaneous tuberculosis by polymerase chain reaction using a species-specific gene. Int J Dermatol 1996 0.80
76 Alpha1 and alpha2 domains of Aotus MHC class I and Catarrhini MHC class Ia share similar characteristics. Tissue Antigens 2003 0.79
77 Erythema nodosum leprosum. Arch Dermatol 1977 0.79
78 Functional, immunological and three-dimensional analysis of chemically synthesised sporozoite peptides as components of a fully-effective antimalarial vaccine. Curr Med Chem 2011 0.79
79 Evaluation of SPf66 malaria vaccine during a 22-month follow-up field trial in the Pacific coast of Colombia. Vaccine 1996 0.79
80 Flow cytometry, a useful tool for detecting the lethal effect of pentamidine on Leishmania viannia complex promastigote forms. Pharmacol Res 2001 0.79
81 Synthetic peptides from Plasmodium falciparum apical membrane antigen 1 (AMA-1) specifically interacting with human hepatocytes. Biochimie 2006 0.78
82 Amino terminal peptides of the ring infected erythrocyte surface antigen of Plasmodium falciparum bind specifically to erythrocytes. Vaccine 2000 0.78
83 Plasmodium falciparum circumsporozoite (CS) protein peptides specifically bind to HepG2 cells. Vaccine 2001 0.78
84 Immune response after oral administration of the encapsulated malaria synthetic peptide SPf66. Int J Pharm 2003 0.78
85 Immunological and structural characterization of an epitope from the Trypanosoma cruzi KMP-11 protein. Peptides 2007 0.78
86 Serine repeat antigen peptides which bind specifically to red blood cells. Parasitol Int 2000 0.78
87 Characterizing T-cell receptor gamma-variable gene in Aotus nancymaae owl monkey peripheral blood. Tissue Antigens 2003 0.77
88 Prevalence of infection with high-risk human papillomavirus in women in Colombia. Clin Microbiol Infect 2008 0.77
89 Plasmodium falciparum: binding studies of peptide derived from the sporozoite surface protein 2 to Hep G2 cells. J Pept Res 2001 0.77
90 In human malaria protective antibodies are directed mainly against the Lys-Glu ion pair within the Lys-Glu-Lys motif of the synthetic vaccine SPf 66. Parasite Immunol 1992 0.77
91 Identification of a Trypanosoma cruzi antigenic epitope implicated in the infectivity of fibroblast LLC-MK2 cells. Parasitol Res 1997 0.77
92 Study of the safety and immunogenicity of the synthetic malaria SPf66 vaccine in children aged 1-14 years. Vaccine 1992 0.77
93 Peptides derived from Mycobacterium tuberculosis Rv2301 protein are involved in invasion to human epithelial cells and macrophages. Amino Acids 2011 0.77
94 Double dimer peptide constructs are immunogenic and protective against Plasmodium falciparum in the experimental Aotus monkey model. J Pept Res 2002 0.77
95 Mapping of the antigenic determinants of the Leishmania infantum gp63 protein recognized by antibodies elicited during canine visceral leishmaniasis. Parasitology 1997 0.76
96 Schistosoma mansoni infection in owl monkeys (Aontus nancymai): evidence for the early elimination of adult worms. Acta Trop 1998 0.76
97 Comparative analysis of CD45 proteins in primate context: owl monkeys vs humans. Tissue Antigens 2004 0.76
98 Epitopes of the Plasmodium falciparum clustered-asparagine-rich protein (CARP) recognized by human T-cells and antibodies. Parasite Immunol 1991 0.76
99 Development of an asexual blood stage malaria vaccine. Blood 1989 0.75
100 Leishmania panamensis: a 44bp deletion in gp63 gene is found in cDNA and genomic libraries. Mem Inst Oswaldo Cruz 1999 0.75
101 Malaria vaccines. J Clin Immunol 1996 0.75
102 Reduced amide pseudopeptide analogues of a malaria peptide possess secondary structural elements responsible for induction of functional antibodies which react with native proteins expressed in Plasmodium falciparum erythrocyte stages. J Pept Res 1998 0.75
103 Stability indicating method for SPf66 antimalarial peptide in solution. Drug Dev Ind Pharm 2004 0.75
104 Comparison of prevalence of anti-hepatitis C virus antibodies in differing South American populations. J Med Virol 1996 0.75
105 The effects of RGD (Arg-Gly-Asp) peptides on glaucoma filtration surgery in rabbits. Ophthalmic Surg Lasers 1998 0.75
106 Identification of five different IGHV gene families in owl monkeys (Aotus nancymaae). Tissue Antigens 2005 0.75
107 Plasmodium falciparum: polymorphism in regions II and III of the knob-associated histidine-rich protein gene from two areas of different endemicity. Exp Parasitol 2000 0.75
108 Genetic restriction in two conserved regions of Plasmodium falciparum EBA-1751t. Mol Biochem Parasitol 1997 0.75
109 [Science in Colombia: from utopia to reality]. Int Microbiol 1998 0.75
110 A specific T-cell receptor genotype preference in the immune response to a synthetic Plasmodium falciparum malaria vaccine. Parasite Immunol 1992 0.75
111 Identification of a differentially expressed mRNA in axenic Leishmania panamensis amastigotes. Mem Inst Oswaldo Cruz 2001 0.75
112 Isolation, characterization, molecular cloning and amplification of a species-specific M. leprae antigen. Int J Lepr Other Mycobact Dis 1999 0.75
113 Alpha helix shortening in 1522 MSP-1 conserved peptide analogs is associated with immunogenicity and protection against P. falciparum malaria. Proteins 2003 0.75
114 GGRGDSPCA peptide: a new antiscarring agent on glaucoma filtration surgery. Ophthalmic Surg Lasers 2001 0.75
115 Proteolytic processing of the Cyt1Ab1 toxin produced by Bacillus thuringiensis subsp. medellin. Mem Inst Oswaldo Cruz 2000 0.75
116 A GBP 130 derived peptide from Plasmodium falciparum binds to human erythrocytes and inhibits merozoite invasion in vitro. Mem Inst Oswaldo Cruz 2000 0.75
117 Immunological and functional characterization of proteins of the Mycobacterium tuberculosis antigen 85 complex using synthetic peptides. J Gen Microbiol 1993 0.75